| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.712 | 0.003 | 0.712 | Histamine H1 receptor antagonist | 0.453 0.004 CID_40584683 | ||
| 0.56 | 0.003 | 0.594 | Poly(ADP-ribose) polymerase inhibitor | 0.594 0.003 CID_40584683 | CID_40584683 | |
| 0.555 | 0.004 | 0.555 | Antihistaminic | 0.376 0.007 CID_40584683 | ||
| 0.552 | 0.004 | 0.552 | Histamine antagonist | 0.374 0.007 CID_40584683 | ||
| 0.531 | 0.003 | 0.56 | Poly(ADP-ribose) polymerase 1 inhibitor | 0.56 0.003 CID_40584683 | CID_40584683 | |
| 0.512 | 0.025 | 0.512 | Histamine release inhibitor | 0.469 0.041 CID_40584683 | ||
| 0.452 | 0.005 | 0.452 | Phosphodiesterase inhibitor | 0.445 0.005 CID_40584683 | ||
| 0.457 | 0.063 | 0.457 | Analgesic | 0.406 0.082 CID_40584683 | ||
| 0.425 | 0.051 | 0.426 | Toll-Like receptor 7 agonist | 0.426 0.05 CID_40584683 | CID_40584683 | |
| 0.418 | 0.053 | 0.419 | Toll-Like receptor agonist | 0.419 0.053 CID_40584683 | CID_40584683 | |
| 0.351 | 0.006 | 0.351 | Alpha 1b adrenoreceptor antagonist | 0.245 0.01 CID_40584683 | ||
| 0.338 | 0.004 | 0.338 | Phosphodiesterase I inhibitor | 0.241 0.007 CID_40584683 | ||
| 0.335 | 0.005 | 0.341 | Phosphodiesterase 4D inhibitor | 0.341 0.005 CID_40584683 | CID_40584683 | |
| 0.328 | 0.005 | 0.384 | Phosphodiesterase IV inhibitor | 0.384 0.004 CID_40584683 | CID_40584683 | |
| 0.314 | 0.004 | 0.314 | Histamine H3 receptor antagonist | 0.264 0.004 CID_40584683 | ||
| 0.263 | 0.005 | 0.268 | Phosphodiesterase 4A inhibitor | 0.268 0.005 CID_40584683 | CID_40584683 | |
| 0.314 | 0.065 | 0.314 | Spasmolytic | 0.197 0.122 CID_40584683 | ||
| 0.25 | 0.005 | 0.25 | 5 Hydroxytryptamine 3A agonist | 0.219 0.01 CID_40584683 | ||
| 0.335 | 0.095 | 0.435 | Antiobesity | 0.435 0.054 CID_40584683 | CID_40584683 | |
| 0.25 | 0.015 | 0.25 | Alpha 1 adrenoreceptor antagonist | 0.188 0.022 CID_40584683 | ||
| 0.236 | 0.005 | 0.274 | Phosphodiesterase 4B inhibitor | 0.274 0.005 CID_40584683 | CID_40584683 | |
| 0.235 | 0.013 | 0.235 | Alpha 1a adrenoreceptor antagonist | 0.186 0.018 CID_40584683 | ||
| 0.24 | 0.021 | 0.24 | Alpha adrenoreceptor antagonist | 0.187 0.029 CID_40584683 | ||
| 0.214 | 0.005 | 0.22 | Phosphodiesterase 4C inhibitor | 0.22 0.005 CID_40584683 | CID_40584683 | |
| 0.272 | 0.065 | 0.287 | Tumour necrosis factor alpha release inhibitor | 0.287 0.059 CID_40584683 | CID_40584683 | |
| 0.226 | 0.023 | 0.233 | Cyclin-dependent kinase 8 inhibitor | 0.233 0.02 CID_40584683 | CID_40584683 | |
| 0.21 | 0.009 | 0.222 | Phosphodiesterase 7B inhibitor | 0.222 0.008 CID_40584683 | CID_40584683 | |
| 0.19 | 0.005 | 0.19 | Phosphodiesterase 1B inhibitor | 0.105 0.013 CID_40584683 | ||
| 0.244 | 0.069 | 0.244 | HERG channel blocker | 0.22 0.079 CID_40584683 | ||
| 0.264 | 0.096 | 0.264 | Nootropic | 0.225 0.13 CID_40584683 | ||
| 0.163 | 0.004 | 0.163 | Phosphodiesterase VII inhibitor | 0.159 0.004 CID_40584683 | ||
| 0.232 | 0.076 | 0.232 | Potassium channel (Voltage-sensitive) blocker | 0.214 0.087 CID_40584683 | ||
| 0.158 | 0.004 | 0.158 | Phosphodiesterase 1A inhibitor | 0.098 0.01 CID_40584683 | ||
| 0.16 | 0.008 | 0.16 | 5 Hydroxytryptamine 3 antagonist | 0.093 0.019 CID_40584683 | ||
| 0.236 | 0.09 | 0.236 | 5 Hydroxytryptamine 1E antagonist | |||
| 0.208 | 0.065 | 0.208 | Non-steroidal antiinflammatory agent | 0.201 0.07 CID_40584683 | ||
| 0.167 | 0.026 | 0.167 | Bronchodilator | 0.166 0.026 CID_40584683 | ||
| 0.249 | 0.108 | 0.249 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.228 0.128 CID_40584683 | ||
| 0.143 | 0.011 | 0.143 | Bromodomain-containing protein 2 inhibitor | 0.126 0.019 CID_40584683 | ||
| 0.183 | 0.062 | 0.183 | Antipruritic | 0.139 0.108 CID_40584683 | ||
| 0.124 | 0.004 | 0.124 | Phosphodiesterase 7A inhibitor | 0.122 0.004 CID_40584683 | ||
| 0.158 | 0.059 | 0.184 | Hemostatic | 0.184 0.04 CID_40584683 | CID_40584683 | |
| 0.102 | 0.01 | 0.102 | Phosphodiesterase 1C inhibitor | 0.081 0.019 CID_40584683 | ||
| 0.113 | 0.021 | 0.113 | Phosphodiesterase 5A inhibitor | 0.096 0.029 CID_40584683 | ||
| 0.114 | 0.023 | 0.114 | Phosphodiesterase XI inhibitor | 0.099 0.033 CID_40584683 | ||
| 0.114 | 0.023 | 0.114 | Phosphodiesterase 11A inhibitor | 0.099 0.033 CID_40584683 | ||
| 0.112 | 0.022 | 0.112 | Phosphodiesterase V inhibitor | 0.096 0.03 CID_40584683 | ||
| 0.21 | 0.133 | 0.266 | 5 Hydroxytryptamine uptake stimulant | 0.266 0.066 CID_40584683 | CID_40584683 | |
| 0.183 | 0.108 | 0.183 | Cyclic AMP phosphodiesterase inhibitor | 0.155 0.144 CID_40584683 | ||
| 0.109 | 0.04 | 0.109 | Acetylcholine M3 receptor agonist | 0.1 0.045 CID_40584683 | ||
| 0.074 | 0.01 | 0.074 | Bromodomain-containing protein 3 inhibitor | 0.068 0.014 CID_40584683 | ||
| 0.095 | 0.031 | 0.095 | Cannabinoid receptor antagonist | 0.093 0.032 CID_40584683 | ||
| 0.169 | 0.108 | 0.169 | Anticonvulsant | |||
| 0.163 | 0.105 | 0.178 | MAP kinase kinase 5 inhibitor | 0.178 0.066 CID_40584683 | CID_40584683 | |
| 0.081 | 0.026 | 0.084 | Cannabinoid CB1 receptor antagonist | 0.084 0.024 CID_40584683 | CID_40584683 | |
| 0.11 | 0.06 | 0.11 | Vascular endothelial growth factor 1 antagonist | 0.102 0.064 CID_40584683 | ||
| 0.112 | 0.062 | 0.112 | Acetylcholine release stimulant | |||
| 0.065 | 0.017 | 0.065 | Smo receptor antagonist | 0.058 0.02 CID_40584683 | ||
| 0.097 | 0.049 | 0.097 | Acetylcholine agonist | 0.079 0.067 CID_40584683 | ||
| 0.083 | 0.036 | 0.083 | MAP3K7 inhibitor | 0.068 0.058 CID_40584683 | ||
| 0.074 | 0.029 | 0.075 | MDM2 inhibitor | 0.075 0.027 CID_40584683 | CID_40584683 | |
| 0.156 | 0.111 | 0.156 | Psychostimulant | 0.147 0.119 CID_40584683 | ||
| 0.167 | 0.122 | 0.182 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | 0.182 0.106 CID_40584683 | CID_40584683 | |
| 0.074 | 0.032 | 0.074 | 5 Hydroxytryptamine 3 agonist | 0.057 0.055 CID_40584683 | ||
| 0.054 | 0.014 | 0.054 | Nerve growth factor antagonist | |||
| 0.132 | 0.093 | 0.132 | Acetylcholine M1 receptor antagonist | |||
| 0.12 | 0.086 | 0.12 | Toll-Like receptor 9 antagonist | |||
| 0.044 | 0.01 | 0.082 | Poly(ADP-ribose) polymerase 2 inhibitor | 0.082 0.005 CID_40584683 | CID_40584683 | |
| 0.076 | 0.042 | 0.076 | Phosphodiesterase VIII inhibitor | 0.075 0.043 CID_40584683 | ||
| 0.2 | 0.167 | 0.239 | Ca2+/calmodulin-dependent kinase IV inhibitor | 0.239 0.08 CID_40584683 | CID_40584683 | |
| 0.064 | 0.031 | 0.064 | Acetylcholine muscarinic agonist | |||
| 0.055 | 0.024 | 0.055 | Acetylcholine M1 receptor agonist | |||
| 0.198 | 0.167 | 0.198 | Immunomodulator | |||
| 0.078 | 0.049 | 0.078 | Acetylcholine M4 receptor antagonist | |||
| 0.045 | 0.018 | 0.125 | 5 Hydroxytryptamine 2B agonist | 0.125 0.004 CID_40584683 | CID_40584683 | |
| 0.052 | 0.026 | 0.052 | Neurokinin 3 antagonist | 0.05 0.028 CID_40584683 | ||
| 0.067 | 0.045 | 0.067 | 5 Hydroxytryptamine 3A antagonist | |||
| 0.061 | 0.04 | 0.061 | Alpha 1d adrenoreceptor antagonist | |||
| 0.268 | 0.247 | 0.268 | Antiinflammatory | |||
| 0.068 | 0.047 | 0.076 | Cyclin B3 inhibitor | 0.076 0.041 CID_40584683 | CID_40584683 | |
| 0.086 | 0.065 | 0.086 | Antiadrenergic | 0.081 0.07 CID_40584683 | ||
| 0.06 | 0.041 | 0.06 | Acetylcholine M5 receptor antagonist | |||
| 0.028 | 0.01 | 0.032 | Phosphodiesterase IX inhibitor | 0.032 0.007 CID_40584683 | CID_40584683 | |
| 0.093 | 0.075 | 0.093 | Nav1.1 sodium channel blocker | |||
| 0.049 | 0.033 | 0.049 | Histamine H4 receptor antagonist | 0.046 0.038 CID_40584683 | ||
| 0.082 | 0.066 | 0.082 | Adrenaline antagonist | 0.077 0.071 CID_40584683 | ||
| 0.027 | 0.013 | 0.03 | Phosphodiesterase 9A inhibitor | 0.03 0.009 CID_40584683 | CID_40584683 | |
| 0.168 | 0.154 | 0.168 | Cardiotonic | |||
| 0.112 | 0.098 | 0.112 | Toll-Like receptor antagonist | |||
| 0.051 | 0.037 | 0.085 | 5 Hydroxytryptamine 2 agonist | 0.085 0.013 CID_40584683 | CID_40584683 | |
| 0.043 | 0.03 | 0.069 | GABA B receptor antagonist | 0.069 0.009 CID_40584683 | CID_40584683 | |
| 0.063 | 0.051 | 0.063 | Acetylcholine M5 receptor agonist | |||
| 0.148 | 0.137 | 0.148 | Potassium channel blocker | |||
| 0.046 | 0.036 | 0.046 | Dopamine transporter inhibitor | |||
| 0.122 | 0.112 | 0.122 | Sigma receptor agonist | |||
| 0.047 | 0.039 | 0.047 | Cannabinoid CB2 receptor antagonist | |||
| 0.058 | 0.05 | 0.058 | Corticotropin releasing factor 2 receptor antagonist | |||
| 0.034 | 0.026 | 0.034 | Adenosine uptake inhibitor | |||
| 0.1 | 0.093 | 0.1 | Interleukin 2 antagonist | |||
| 0.113 | 0.107 | 0.113 | Neurotrophic factor | |||
| 0.046 | 0.04 | 0.072 | Topoisomerase II beta inhibitor | 0.072 0.016 CID_40584683 | CID_40584683 | |
| 0.05 | 0.044 | 0.053 | Nicotinic alpha3beta2 receptor antagonist | 0.053 0.038 CID_40584683 | CID_40584683 | |
| 0.058 | 0.053 | 0.058 | Dopamine D1 antagonist | |||
| 0.072 | 0.068 | 0.087 | Acetylcholine nicotinic agonist | 0.087 0.048 CID_40584683 | CID_40584683 | |
| 0.068 | 0.065 | 0.077 | Nicotinic alpha4beta2 receptor antagonist | 0.077 0.054 CID_40584683 | CID_40584683 | |
| 0.073 | 0.07 | 0.073 | ALK inhibitor | |||
| 0.124 | 0.122 | 0.143 | MAP kinase 3 inhibitor | 0.143 0.08 CID_40584683 | CID_40584683 | |
| 0.054 | 0.052 | 0.068 | 5 Hydroxytryptamine uptake inhibitor | 0.068 0.04 CID_40584683 | CID_40584683 | |
| 0.083 | 0.08 | 0.089 | Protein kinase C zeta inhibitor | 0.089 0.067 CID_40584683 | CID_40584683 | |
| 0.051 | 0.048 | 0.051 | Dopamine uptake inhibitor | |||
| 0.011 | 0.008 | 0.011 | CD80 antagonist | |||
| 0.036 | 0.035 | 0.036 | Neurokinin 2 antagonist | |||
| 0.048 | 0.047 | 0.048 | Dipeptidyl peptidase inhibitor | |||
| 0.031 | 0.038 | 0.048 | Somatostatin 4 agonist | 0.048 0.016 CID_40584683 | CID_40584683 | |
| 0.053 | 0.06 | 0.056 | Potassium channel (Ca-activated) blocker | 0.056 0.05 CID_40584683 | CID_40584683 | |
| 0.185 | 0.194 | 0.197 | Vasodilator, peripheral | 0.197 0.18 CID_40584683 | CID_40584683 | |
| 0.04 | 0.052 | 0.044 | Neurokinin antagonist | 0.044 0.043 CID_40584683 | CID_40584683 | |
| 0.047 | 0.064 | 0.061 | Adrenaline uptake inhibitor | 0.061 0.043 CID_40584683 | CID_40584683 | |
| 0.066 | 0.088 | 0.105 | NMDA receptor antagonist | 0.105 0.044 CID_40584683 | CID_40584683 | |
| 0.039 | 0.062 | 0.053 | Nicotinic neuronal receptor agonist | 0.053 0.043 CID_40584683 | CID_40584683 | |
| 0.028 | 0.052 | 0.096 | 5 Hydroxytryptamine 2C agonist | 0.096 0.008 CID_40584683 | CID_40584683 | |
| 0.09 | 0.125 | 0.116 | Cytokine production inhibitor | 0.116 0.093 CID_40584683 | CID_40584683 | |
| 0.037 | 0.079 | 0.045 | Nicotinic receptor alpha4 subunit antagonist | 0.045 0.044 CID_40584683 | CID_40584683 | |
| 0.243 | 0.3 | 0.279 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.279 0.243 CID_40584683 | CID_40584683 | |
| 0.032 | 0.102 | 0.075 | 5 Hydroxytryptamine 2A agonist | 0.075 0.032 CID_40584683 | CID_40584683 | |
| 0.1 | 0.177 | 0.122 | Neuropeptide Y1 antagonist | 0.122 0.119 CID_40584683 | CID_40584683 | |
| 0.03 | 0.11 | 0.041 | Alpha 1L adrenoreceptor agonist | 0.041 0.036 CID_40584683 | CID_40584683 | |
| 0.138 | 0.433 | 0.248 | Calcium channel L-type activator | 0.248 0.207 CID_40584683 | CID_40584683 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |